Securities Code: 002360 Securities Abbreviation: Tongde Chemical Announcement No.: 2026-045
Shanxi Tongde Chemical Co., Ltd.
Announcement on Re-appointment of 2026 Audit Firm
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.
Special Notes:
- In 2025, Lixin Zhonglian Certified Public Accountants (Special General Partnership) issued a qualified audit report for the Company.
- Proposed Re-appointment of Audit Firm: Lixin Zhonglian Certified Public Accountants (Special General Partnership).
Shanxi Tongde Chemical Co., Ltd. (hereinafter referred to as "Tongde Chemical" or the "Company") held the nineteenth meeting of the Eighth Board of Directors on April 25, 2026, and deliberated and passed the "Proposal on Re-appointment of the 2026 Audit Firm." The Company's Board of Directors agreed to re-appoint Lixin Zhonglian Certified Public Accountants (Special General Partnership) (hereinafter referred to as "Lixin Zhonglian") as the Company's audit institution for financial reports and internal control for 2026. The relevant situation is explained as follows:
I. Explanation of the Proposed Appointment of Audit Firm
Lixin Zhonglian was appointed by the Company as the financial audit institution and internal control audit institution for 2025 on January 1, 2026. It has followed independent, objective, and fair professional standards and issued reports that objectively and truthfully reflect the Company's actual situation, financial status, and operating results. To ensure the continuity of the Company's audit work, the Company proposes to re-appoint Lixin Zhonglian as the audit institution for the Company's 2026 financial reports and internal control. The term of appointment is one year. The relevant audit fees will be determined through negotiation between the Company's management, authorized by the shareholders' meeting, and the audit institution, based on the audit institution's workload and current market price levels. This matter still needs to be submitted to the 2025 shareholders' meeting for deliberation and approval before it takes effect.